

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.53052699 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.92030998 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58294618 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.58294618 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.38779300 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24090137 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.24090137 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.82850817 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.48469283 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.16699478 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.16699478 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.16699478 |
| 13 | drug metabolic process (GO:0017144) | 6.06786315 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.02774152 |
| 15 | oxidative demethylation (GO:0070989) | 5.98777580 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.94896511 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.81189258 |
| 18 | phenylpropanoid metabolic process (GO:0009698) | 5.80093419 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.76867717 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.73266314 |
| 21 | urea metabolic process (GO:0019627) | 5.72707105 |
| 22 | urea cycle (GO:0000050) | 5.72707105 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.72638960 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.59545746 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.53687113 |
| 26 | protein carboxylation (GO:0018214) | 5.43137475 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43137475 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.34153822 |
| 29 | cysteine metabolic process (GO:0006534) | 5.33111435 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.32976574 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.26073983 |
| 32 | regulation of plasminogen activation (GO:0010755) | 5.26009021 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.14223380 |
| 34 | * regulation of protein activation cascade (GO:2000257) | 5.13786202 |
| 35 | bile acid metabolic process (GO:0008206) | 5.10914769 |
| 36 | reverse cholesterol transport (GO:0043691) | 5.02778098 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 5.00539836 |
| 38 | regulation of complement activation (GO:0030449) | 4.98172595 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.96476662 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.95807577 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.95807577 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.91587987 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.91587987 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.91587987 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.89927289 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85049253 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.83376834 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.76589049 |
| 49 | ethanol metabolic process (GO:0006067) | 4.75130317 |
| 50 | phospholipid efflux (GO:0033700) | 4.72244689 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.69186139 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.69186139 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.64530930 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.61175702 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.61175702 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.60266604 |
| 57 | alkaloid metabolic process (GO:0009820) | 4.58410187 |
| 58 | negative regulation of protein activation cascade (GO:2000258) | 4.56257655 |
| 59 | acute-phase response (GO:0006953) | 4.51534520 |
| 60 | negative regulation of coagulation (GO:0050819) | 4.50492407 |
| 61 | negative regulation of wound healing (GO:0061045) | 4.50361624 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.49809472 |
| 63 | lysine metabolic process (GO:0006553) | 4.49691327 |
| 64 | lysine catabolic process (GO:0006554) | 4.49691327 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.47850732 |
| 66 | regulation of humoral immune response (GO:0002920) | 4.45903612 |
| 67 | hormone catabolic process (GO:0042447) | 4.44946131 |
| 68 | bile acid and bile salt transport (GO:0015721) | 4.43658171 |
| 69 | S-adenosylmethionine metabolic process (GO:0046500) | 4.42486620 |
| 70 | glycine metabolic process (GO:0006544) | 4.42248818 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 4.38610912 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.38568889 |
| 73 | cholesterol efflux (GO:0033344) | 4.34707327 |
| 74 | coenzyme catabolic process (GO:0009109) | 4.34322763 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.30484751 |
| 76 | amine catabolic process (GO:0009310) | 4.30484751 |
| 77 | positive regulation of hemostasis (GO:1900048) | 4.28407861 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 4.28407861 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 4.26685709 |
| 80 | cellular glucuronidation (GO:0052695) | 4.26458929 |
| 81 | glutamate metabolic process (GO:0006536) | 4.23266456 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 4.17295865 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 4.15300384 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.12143692 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 4.11654862 |
| 86 | fibrinolysis (GO:0042730) | 4.08875936 |
| 87 | arginine metabolic process (GO:0006525) | 4.05599166 |
| 88 | ethanol oxidation (GO:0006069) | 4.04185480 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.03975047 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.03293041 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03260308 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 4.02147829 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97120044 |
| 94 | positive regulation of coagulation (GO:0050820) | 3.95375318 |
| 95 | drug catabolic process (GO:0042737) | 3.94712610 |
| 96 | negative regulation of complement activation (GO:0045916) | 3.93759913 |
| 97 | steroid catabolic process (GO:0006706) | 3.91597657 |
| 98 | heme transport (GO:0015886) | 3.89677010 |
| 99 | ketone body metabolic process (GO:1902224) | 3.87539084 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87367001 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87367001 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.86517356 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83231127 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.82090356 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.81923205 |
| 106 | cofactor catabolic process (GO:0051187) | 3.80640635 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.78805674 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.78805674 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.78526160 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.78410539 |
| 111 | protein activation cascade (GO:0072376) | 3.75906880 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.75406787 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.75359109 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.73755680 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.73295591 |
| 116 | organic acid catabolic process (GO:0016054) | 3.73295591 |
| 117 | complement activation (GO:0006956) | 3.72743485 |
| 118 | sterol homeostasis (GO:0055092) | 3.72008391 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71012139 |
| 120 | regulation of lipoprotein particle clearance (GO:0010984) | 3.68462407 |
| 121 | protein-lipid complex assembly (GO:0065005) | 3.68060059 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.65008949 |
| 123 | daunorubicin metabolic process (GO:0044597) | 3.64649054 |
| 124 | polyketide metabolic process (GO:0030638) | 3.64649054 |
| 125 | doxorubicin metabolic process (GO:0044598) | 3.64649054 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.61184985 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.60404085 |
| 128 | cytolysis (GO:0019835) | 3.60206060 |
| 129 | opsonization (GO:0008228) | 3.59486293 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.56062818 |
| 131 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55783380 |
| 132 | xenobiotic metabolic process (GO:0006805) | 3.54523885 |
| 133 | acute inflammatory response (GO:0002526) | 3.53340310 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.52797244 |
| 135 | drug transmembrane transport (GO:0006855) | 3.49013984 |
| 136 | response to mercury ion (GO:0046689) | 3.47675839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43271231 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20355331 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11779562 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53605555 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33483834 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13599884 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.75376263 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07298859 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97393545 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07913890 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9732084 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92889388 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89874674 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62932647 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61620945 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47376253 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45173052 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40969168 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29270922 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25653572 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21904024 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21351686 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20205094 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14269264 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07720166 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03911965 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00061178 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93060111 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90869262 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89726021 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89068093 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87742292 |
| 33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85243878 |
| 34 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84965391 |
| 35 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84142117 |
| 36 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.80870565 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80458244 |
| 38 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80165489 |
| 39 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78652775 |
| 40 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77371857 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76226981 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76192140 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75271587 |
| 44 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.74595080 |
| 45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73744197 |
| 46 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73551063 |
| 47 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.73351615 |
| 48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.72721595 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72676552 |
| 50 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70199551 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69605010 |
| 52 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69391449 |
| 53 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.68573811 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67193981 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66426963 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66344680 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66344680 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64968347 |
| 59 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.64543442 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.63730699 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63529400 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63152797 |
| 63 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62656070 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61604847 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61578409 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61534566 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61366082 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60107249 |
| 69 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.59908838 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.59236932 |
| 71 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59206047 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.58618056 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58126773 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.58111679 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57295335 |
| 76 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57192203 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56900433 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56093946 |
| 79 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.56014378 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55338778 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54983570 |
| 82 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.54667309 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54477141 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54188837 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.53988398 |
| 86 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53635950 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.53498557 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53291438 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.52471230 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52220831 |
| 91 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.51946550 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.51888996 |
| 93 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51696302 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51604340 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.51403796 |
| 96 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.51336338 |
| 97 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.51043654 |
| 98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.50743022 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50293596 |
| 100 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49958538 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49756713 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 0.49499567 |
| 103 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.49498329 |
| 104 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.49490720 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.49324600 |
| 106 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.49295814 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47038473 |
| 108 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46900944 |
| 109 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.44802033 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.44781054 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44295732 |
| 112 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43391567 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42534396 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42480866 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42258073 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42055027 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41891956 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41716685 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41496790 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40272127 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40178070 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39907623 |
| 123 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.39440508 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39251432 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39071686 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38809520 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38703873 |
| 128 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38545699 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37641471 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37527221 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.36498209 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36217965 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36163064 |
| 134 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.35769915 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35608604 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35537916 |
| 137 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35173524 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.34879388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.36281163 |
| 2 | MP0005360_urolithiasis | 7.55849890 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48432663 |
| 4 | MP0005365_abnormal_bile_salt | 6.23103646 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13856694 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26207187 |
| 7 | MP0003252_abnormal_bile_duct | 3.93373071 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.64236841 |
| 9 | MP0009840_abnormal_foam_cell | 3.33468406 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11015045 |
| 11 | MP0003195_calcinosis | 2.85825755 |
| 12 | MP0005332_abnormal_amino_acid | 2.75886284 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59077635 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.36585388 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.17546711 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.15324681 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11401965 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01505433 |
| 19 | MP0003868_abnormal_feces_composition | 1.94871318 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82637727 |
| 21 | MP0001764_abnormal_homeostasis | 1.71421329 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56671906 |
| 23 | MP0005451_abnormal_body_composition | 1.51020231 |
| 24 | MP0003011_delayed_dark_adaptation | 1.47096062 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.29661099 |
| 26 | MP0003186_abnormal_redox_activity | 1.28767431 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.21322797 |
| 28 | MP0005647_abnormal_sex_gland | 1.16390501 |
| 29 | * MP0000598_abnormal_liver_morphology | 1.15795775 |
| 30 | MP0000604_amyloidosis | 1.09300122 |
| 31 | MP0009764_decreased_sensitivity_to | 1.08543729 |
| 32 | MP0002254_reproductive_system_inflammat | 1.06565574 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.04982396 |
| 34 | MP0009763_increased_sensitivity_to | 1.03972117 |
| 35 | MP0010368_abnormal_lymphatic_system | 0.98522888 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 0.93087378 |
| 37 | MP0008469_abnormal_protein_level | 0.90482996 |
| 38 | MP0005408_hypopigmentation | 0.89232682 |
| 39 | * MP0009642_abnormal_blood_homeostasis | 0.87214550 |
| 40 | MP0002876_abnormal_thyroid_physiology | 0.81924890 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 0.81488149 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.81078977 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.80909129 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.79962324 |
| 45 | MP0005670_abnormal_white_adipose | 0.78422593 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 0.78343262 |
| 47 | MP0005220_abnormal_exocrine_pancreas | 0.73456489 |
| 48 | MP0002971_abnormal_brown_adipose | 0.71359968 |
| 49 | MP0005334_abnormal_fat_pad | 0.69674023 |
| 50 | MP0001661_extended_life_span | 0.68098383 |
| 51 | MP0003690_abnormal_glial_cell | 0.67686315 |
| 52 | MP0005535_abnormal_body_temperature | 0.66903319 |
| 53 | MP0003879_abnormal_hair_cell | 0.66226031 |
| 54 | * MP0009697_abnormal_copulation | 0.66088687 |
| 55 | MP0009053_abnormal_anal_canal | 0.65893087 |
| 56 | MP0005058_abnormal_lysosome_morphology | 0.64783514 |
| 57 | MP0004130_abnormal_muscle_cell | 0.64292155 |
| 58 | MP0005266_abnormal_metabolism | 0.63835990 |
| 59 | MP0000639_abnormal_adrenal_gland | 0.63140025 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.61149593 |
| 61 | MP0003329_amyloid_beta_deposits | 0.59916306 |
| 62 | MP0005464_abnormal_platelet_physiology | 0.57468689 |
| 63 | MP0001756_abnormal_urination | 0.57191594 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.56471672 |
| 65 | MP0005448_abnormal_energy_balance | 0.56426642 |
| 66 | * MP0001915_intracranial_hemorrhage | 0.56023207 |
| 67 | MP0003718_maternal_effect | 0.52756125 |
| 68 | MP0005395_other_phenotype | 0.51831194 |
| 69 | MP0002822_catalepsy | 0.49867943 |
| 70 | MP0002249_abnormal_larynx_morphology | 0.48645407 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 0.46953434 |
| 72 | MP0002928_abnormal_bile_duct | 0.46572556 |
| 73 | MP0003724_increased_susceptibility_to | 0.45860580 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.45134368 |
| 75 | MP0008874_decreased_physiological_sensi | 0.44952807 |
| 76 | MP0003436_decreased_susceptibility_to | 0.44587672 |
| 77 | MP0008873_increased_physiological_sensi | 0.44177743 |
| 78 | MP0004381_abnormal_hair_follicle | 0.43534014 |
| 79 | MP0005023_abnormal_wound_healing | 0.42446646 |
| 80 | MP0003953_abnormal_hormone_level | 0.41546995 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.41475879 |
| 82 | * MP0002136_abnormal_kidney_physiology | 0.40045063 |
| 83 | MP0009785_altered_susceptibility_to | 0.40023122 |
| 84 | MP0003075_altered_response_to | 0.39975901 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.38124644 |
| 86 | MP0008872_abnormal_physiological_respon | 0.37610526 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.37592411 |
| 88 | MP0005166_decreased_susceptibility_to | 0.36741763 |
| 89 | MP0009672_abnormal_birth_weight | 0.36164333 |
| 90 | MP0000579_abnormal_nail_morphology | 0.35349580 |
| 91 | MP0004883_abnormal_blood_vessel | 0.34768544 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.34397815 |
| 93 | MP0006082_CNS_inflammation | 0.34161858 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.33852909 |
| 95 | MP0009115_abnormal_fat_cell | 0.33137131 |
| 96 | MP0001243_abnormal_dermal_layer | 0.32947279 |
| 97 | MP0000566_synostosis | 0.31753239 |
| 98 | MP0001853_heart_inflammation | 0.31574407 |
| 99 | MP0002168_other_aberrant_phenotype | 0.31107455 |
| 100 | MP0002796_impaired_skin_barrier | 0.31097832 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.30964293 |
| 102 | MP0002970_abnormal_white_adipose | 0.29726219 |
| 103 | MP0002132_abnormal_respiratory_system | 0.29640523 |
| 104 | MP0003959_abnormal_lean_body | 0.28569411 |
| 105 | MP0001881_abnormal_mammary_gland | 0.28197365 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.28035430 |
| 107 | MP0005164_abnormal_response_to | 0.27161653 |
| 108 | * MP0001845_abnormal_inflammatory_respons | 0.26959768 |
| 109 | * MP0000249_abnormal_blood_vessel | 0.26415015 |
| 110 | MP0002090_abnormal_vision | 0.23973404 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.23943395 |
| 112 | MP0000427_abnormal_hair_cycle | 0.23831977 |
| 113 | MP0004272_abnormal_basement_membrane | 0.21097233 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.19445176 |
| 115 | MP0001851_eye_inflammation | 0.19400034 |
| 116 | MP0000920_abnormal_myelination | 0.19362426 |
| 117 | MP0003632_abnormal_nervous_system | 0.17281215 |
| 118 | MP0003633_abnormal_nervous_system | 0.14748788 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.14096994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.43705875 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.35660458 |
| 3 | * Deep venous thrombosis (HP:0002625) | 6.94867889 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.76131542 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70551722 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.54864143 |
| 7 | Xanthomatosis (HP:0000991) | 6.34976109 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.63424697 |
| 9 | Complement deficiency (HP:0004431) | 5.34172514 |
| 10 | Joint hemorrhage (HP:0005261) | 4.98969573 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.90067928 |
| 12 | Hyperammonemia (HP:0001987) | 4.61277099 |
| 13 | Epidermoid cyst (HP:0200040) | 4.55314896 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55111377 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48121199 |
| 16 | Hyperglycinemia (HP:0002154) | 4.43794473 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.34734552 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.27781548 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24788969 |
| 20 | Ketosis (HP:0001946) | 4.22536956 |
| 21 | Fat malabsorption (HP:0002630) | 4.16473803 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15210693 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14798292 |
| 24 | Hyperglycinuria (HP:0003108) | 3.91271159 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.90787762 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90587872 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.90587872 |
| 28 | Abnormality of complement system (HP:0005339) | 3.89443900 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.87314353 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83130611 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82072878 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.68433583 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.39507555 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35644838 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31888668 |
| 36 | Spontaneous abortion (HP:0005268) | 3.12422275 |
| 37 | Steatorrhea (HP:0002570) | 3.11912330 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.10914170 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.07987337 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 3.06804550 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06297134 |
| 42 | Osteomalacia (HP:0002749) | 3.06235323 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.02530260 |
| 44 | Ketoacidosis (HP:0001993) | 2.96842988 |
| 45 | Myocardial infarction (HP:0001658) | 2.95234437 |
| 46 | Skin nodule (HP:0200036) | 2.77847556 |
| 47 | Metabolic acidosis (HP:0001942) | 2.77134214 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.72388216 |
| 49 | Acanthocytosis (HP:0001927) | 2.67938031 |
| 50 | Purpura (HP:0000979) | 2.65162218 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.64051819 |
| 52 | Vascular calcification (HP:0004934) | 2.62402830 |
| 53 | Lethargy (HP:0001254) | 2.61099491 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.56443854 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56443854 |
| 56 | Glomerulonephritis (HP:0000099) | 2.53487571 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.53152234 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.49148153 |
| 59 | Cerebral edema (HP:0002181) | 2.43601584 |
| 60 | Mitral stenosis (HP:0001718) | 2.42529202 |
| 61 | Cholelithiasis (HP:0001081) | 2.42246971 |
| 62 | Cholecystitis (HP:0001082) | 2.39383134 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 2.39383134 |
| 64 | Spastic diplegia (HP:0001264) | 2.39262837 |
| 65 | Gout (HP:0001997) | 2.36914137 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36887067 |
| 67 | Amyloidosis (HP:0011034) | 2.35670694 |
| 68 | Irritability (HP:0000737) | 2.34527826 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.31973126 |
| 70 | Gingival bleeding (HP:0000225) | 2.31620076 |
| 71 | Neonatal onset (HP:0003623) | 2.30460867 |
| 72 | Fair hair (HP:0002286) | 2.26774101 |
| 73 | Hyperphosphaturia (HP:0003109) | 2.25273830 |
| 74 | Malnutrition (HP:0004395) | 2.24616506 |
| 75 | Arthropathy (HP:0003040) | 2.22774238 |
| 76 | Menorrhagia (HP:0000132) | 2.22341286 |
| 77 | Esophageal varix (HP:0002040) | 2.21565355 |
| 78 | Elevated alkaline phosphatase (HP:0003155) | 2.18200086 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.18115282 |
| 80 | Pancreatitis (HP:0001733) | 2.16053265 |
| 81 | Enlarged kidneys (HP:0000105) | 2.15226865 |
| 82 | Brushfield spots (HP:0001088) | 2.13989560 |
| 83 | Thrombophlebitis (HP:0004418) | 2.13699208 |
| 84 | Poikilocytosis (HP:0004447) | 2.10480627 |
| 85 | Glycosuria (HP:0003076) | 2.09354997 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.09354997 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.09294177 |
| 88 | Neonatal hypoglycemia (HP:0001998) | 2.08515234 |
| 89 | Late onset (HP:0003584) | 2.08048811 |
| 90 | Vomiting (HP:0002013) | 2.05570905 |
| 91 | Opisthotonus (HP:0002179) | 2.03702443 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03117311 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.02891045 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 2.01703092 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.99751196 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98356678 |
| 97 | Rickets (HP:0002748) | 1.95798464 |
| 98 | Abnormal biliary tract physiology (HP:0012439) | 1.93933123 |
| 99 | Bile duct proliferation (HP:0001408) | 1.93933123 |
| 100 | Renal cortical cysts (HP:0000803) | 1.93711714 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 1.90610816 |
| 102 | Hypophosphatemic rickets (HP:0004912) | 1.89737718 |
| 103 | Increased serum ferritin (HP:0003281) | 1.89063989 |
| 104 | Gangrene (HP:0100758) | 1.88434263 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87775959 |
| 106 | Hydroxyprolinuria (HP:0003080) | 1.83740612 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.83740612 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.83738329 |
| 109 | Elevated hepatic transaminases (HP:0002910) | 1.83023335 |
| 110 | Alkalosis (HP:0001948) | 1.81767139 |
| 111 | Abnormal urine phosphate concentration (HP:0012599) | 1.81612914 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80709246 |
| 113 | * Pulmonary embolism (HP:0002204) | 1.77994384 |
| 114 | Nephritis (HP:0000123) | 1.77714165 |
| 115 | Status epilepticus (HP:0002133) | 1.77182307 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.74721809 |
| 117 | Atrioventricular block (HP:0001678) | 1.74583008 |
| 118 | Bifid scrotum (HP:0000048) | 1.73548003 |
| 119 | Hyperglycemia (HP:0003074) | 1.72238137 |
| 120 | Epistaxis (HP:0000421) | 1.69552202 |
| 121 | Joint swelling (HP:0001386) | 1.64467917 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.62530468 |
| 123 | Retinal atrophy (HP:0001105) | 1.55880655 |
| 124 | Increased serum pyruvate (HP:0003542) | 1.54023088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.19718906 |
| 2 | SIK1 | 4.61183185 |
| 3 | FGFR4 | 4.60102549 |
| 4 | ERN1 | 4.15884950 |
| 5 | TAOK3 | 3.23203886 |
| 6 | INSRR | 3.23072183 |
| 7 | ERBB4 | 2.95560559 |
| 8 | MAP2K4 | 2.33915804 |
| 9 | MST1R | 2.15631095 |
| 10 | PKN2 | 2.03401317 |
| 11 | PIK3CG | 1.94374779 |
| 12 | FLT3 | 1.92441106 |
| 13 | MAPK11 | 1.90120416 |
| 14 | PRPF4B | 1.83484817 |
| 15 | TYK2 | 1.77103217 |
| 16 | LATS1 | 1.70459677 |
| 17 | MAP3K12 | 1.56967154 |
| 18 | DAPK2 | 1.56866216 |
| 19 | ABL2 | 1.51426695 |
| 20 | NEK9 | 1.45880690 |
| 21 | FRK | 1.44331390 |
| 22 | NTRK3 | 1.41540047 |
| 23 | TRIB3 | 1.40891853 |
| 24 | PTK6 | 1.36067890 |
| 25 | FGFR2 | 1.35238737 |
| 26 | KDR | 1.30546147 |
| 27 | PINK1 | 1.22807610 |
| 28 | JAK2 | 1.21317841 |
| 29 | PRKAA2 | 1.17845250 |
| 30 | MAP3K14 | 1.17603371 |
| 31 | MAP3K7 | 1.15355332 |
| 32 | MYLK | 1.14321001 |
| 33 | TBK1 | 1.04712321 |
| 34 | JAK1 | 1.04125126 |
| 35 | MAP2K3 | 1.03901136 |
| 36 | PRKG1 | 1.03066911 |
| 37 | GRK6 | 1.01638081 |
| 38 | MAPK4 | 1.00631750 |
| 39 | ERBB2 | 1.00416605 |
| 40 | STK38L | 0.98963902 |
| 41 | ARAF | 0.93675652 |
| 42 | TNK2 | 0.93591612 |
| 43 | PRKCZ | 0.91413895 |
| 44 | PDK2 | 0.90937151 |
| 45 | PRKACA | 0.90534283 |
| 46 | SCYL2 | 0.90302271 |
| 47 | MAP3K2 | 0.87837398 |
| 48 | TIE1 | 0.87205257 |
| 49 | MAP3K10 | 0.86191623 |
| 50 | MAP3K3 | 0.85779838 |
| 51 | MAPK15 | 0.85550537 |
| 52 | CSNK1D | 0.85286738 |
| 53 | MAPK12 | 0.81287274 |
| 54 | IRAK3 | 0.81285951 |
| 55 | MET | 0.80409365 |
| 56 | EPHA3 | 0.80056409 |
| 57 | SGK1 | 0.78970418 |
| 58 | CDK6 | 0.76928128 |
| 59 | PRKACG | 0.76851235 |
| 60 | MAP3K11 | 0.76788039 |
| 61 | MUSK | 0.76568571 |
| 62 | EPHB1 | 0.75465437 |
| 63 | NLK | 0.71544377 |
| 64 | CAMK2G | 0.71449686 |
| 65 | CSK | 0.70919242 |
| 66 | PRKCB | 0.68773685 |
| 67 | EIF2AK1 | 0.68516566 |
| 68 | DYRK1B | 0.67316532 |
| 69 | GSK3A | 0.66804470 |
| 70 | PRKAA1 | 0.66751157 |
| 71 | MAP2K6 | 0.66447097 |
| 72 | CAMK1D | 0.65932635 |
| 73 | SGK3 | 0.65290002 |
| 74 | ZAP70 | 0.65248059 |
| 75 | RPS6KA3 | 0.63531682 |
| 76 | IKBKE | 0.63227432 |
| 77 | MAPK7 | 0.62557558 |
| 78 | CAMKK1 | 0.58843818 |
| 79 | TGFBR2 | 0.58169667 |
| 80 | GRK1 | 0.57919155 |
| 81 | FGFR3 | 0.56961196 |
| 82 | CSF1R | 0.56736929 |
| 83 | FER | 0.56609657 |
| 84 | PRKCQ | 0.54926923 |
| 85 | SGK2 | 0.54529060 |
| 86 | CAMKK2 | 0.53482382 |
| 87 | TAOK2 | 0.53322983 |
| 88 | KSR2 | 0.52551513 |
| 89 | EPHA4 | 0.51315273 |
| 90 | CSNK1G1 | 0.50463530 |
| 91 | SRC | 0.50302703 |
| 92 | PRKACB | 0.49883053 |
| 93 | PTK2 | 0.49873832 |
| 94 | MAP3K13 | 0.48944321 |
| 95 | WNK3 | 0.48249950 |
| 96 | CSNK1E | 0.48196912 |
| 97 | STK38 | 0.47817352 |
| 98 | RIPK1 | 0.47246182 |
| 99 | PBK | 0.46940201 |
| 100 | CSNK2A2 | 0.46751668 |
| 101 | PIM2 | 0.46599396 |
| 102 | MAP3K5 | 0.45856287 |
| 103 | PDPK1 | 0.45534271 |
| 104 | MAP3K6 | 0.45489583 |
| 105 | IGF1R | 0.45166141 |
| 106 | CSNK2A1 | 0.45094324 |
| 107 | STK16 | 0.44926683 |
| 108 | MAPKAPK3 | 0.44883413 |
| 109 | PKN1 | 0.43064487 |
| 110 | PRKCG | 0.42653521 |
| 111 | CDK4 | 0.39322004 |
| 112 | MAP2K1 | 0.39260762 |
| 113 | PDGFRA | 0.37104949 |
| 114 | SGK223 | 0.36623338 |
| 115 | SGK494 | 0.36623338 |
| 116 | CSNK1A1 | 0.35407165 |
| 117 | TESK2 | 0.35149244 |
| 118 | RET | 0.35064447 |
| 119 | CAMK4 | 0.32561308 |
| 120 | IRAK1 | 0.32463892 |
| 121 | IRAK2 | 0.32173621 |
| 122 | EGFR | 0.30234073 |
| 123 | MTOR | 0.28467151 |
| 124 | CSNK1G2 | 0.27707914 |
| 125 | PDK1 | 0.27125139 |
| 126 | PRKCA | 0.26747543 |
| 127 | ICK | 0.26625842 |
| 128 | MAP3K1 | 0.25762915 |
| 129 | CSNK1G3 | 0.25756999 |
| 130 | AKT3 | 0.24685002 |
| 131 | PIK3CA | 0.23880776 |
| 132 | ABL1 | 0.22310413 |
| 133 | LATS2 | 0.20917611 |
| 134 | MAPK3 | 0.19627148 |
| 135 | CHUK | 0.18159492 |
| 136 | PAK3 | 0.18129791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50919926 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63619987 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37530323 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36565274 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07921327 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75067364 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72872086 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68021156 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61273012 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54374279 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47177565 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36713437 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26342813 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15944504 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14018692 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07639655 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97164973 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95148292 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94693815 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92025238 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91527509 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85503594 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80555450 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80546948 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77621212 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74044431 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72586376 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72165148 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70389870 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66087764 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62138154 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58105136 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56441650 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52352423 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46889272 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.46839472 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44317220 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36705037 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34602936 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34100264 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30861032 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28287460 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24260688 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21629634 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20678143 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18164072 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17177533 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10213950 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05510391 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01811519 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01762531 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98802227 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98235564 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97233588 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93949374 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89513117 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88646677 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.80994986 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79437714 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78965344 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67947225 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66827962 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65178914 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56674401 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54826071 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46434689 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41862337 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39626178 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.33594406 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27508492 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25308107 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23687353 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22041741 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21321225 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.21086490 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20161958 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15833899 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12115983 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08017707 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2599927 |
| 81 | Pertussis_Homo sapiens_hsa05133 | -0.2531523 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2513478 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2466165 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2451510 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2252068 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2147358 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2110623 |
| 88 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1955287 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1922941 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1920094 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1833218 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1785560 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1694340 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1611143 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1576102 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1421429 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1379722 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1321850 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1271052 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1162795 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0914066 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | -0.0767357 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | -0.0680102 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0662566 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0519174 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0475137 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0190631 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0003707 |

